
EDITORIAL BOARD
Maurie Markman, MD
Cancer Treatment Centers of America
Drexel University College of Medicine
Philadelphia, Pennsylvania
Drexel University College of Medicine
Philadelphia, Pennsylvania
Cancer clinical trials have many potential goals. From Phase I studies focusing on dose, schedule, and safety to Phase II studies examining the clinical activity of a specific management strategy in a given clinical setting, and finally to randomized, Phase III efforts comparing one approach with another (generally with respect to efficacy or